P53.04 KUgliptin, a Novel and Potent DPP4 Inhibitor, Improves of Combined Therapy with Immune Checkpoint Inhibitor (ICI) in Lung Cancer Immunotherapy

Subjects

Subjects :

Pulmonary and Respiratory Medicine
Oncology
business.industry
Immune checkpoint inhibitors
medicine.medical_treatment
Cancer research
medicine
Combined therapy
Immunotherapy
Lung cancer
medicine.disease
business

Details

ISSN :

15560864

Volume :

16

Database :

OpenAIRE

Journal :

Journal of Thoracic Oncology

Accession number :

edsair.doi...........d4eb3d8220515f9a438ab845413237bc

Full Text :

https://doi.org/10.1016/j.jtho.2021.01.931